Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Alpha L-Iduronidase Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

The global Alpha L-Iduronidase market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Alpha L-Iduronidase Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

According to our (Global Info Research) latest study, the global Alpha L-Iduronidase market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Alpha L-Iduronidase Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 26 Feb 2023

date Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).

USD3480.00

Add To Cart

Add To Cart

Global Alpha L-Iduronidase Supply, Demand and Key Producers, 2023-2029

date 20 Jan 2023

date Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

The global Alpha L-Iduronidase market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 14 Feb 2024

industry Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

The global Alpha L-Iduronidase market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

According to our (Global Info Research) latest study, the global Alpha L-Iduronidase market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 26 Feb 2023

industry Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).

USD3480.00

addToCart

Add To Cart

industry 20 Jan 2023

industry Pharma & Healthcare

new_biaoQian Alpha L-Iduronidase

The global Alpha L-Iduronidase market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart